Comoxdin ( Co-Amoxiclav 625 mg )

FORMULATION:

Each film-coated tablet contains
Amoxicillin (as trihydrate) USP.....................500mg
Clavulanic acid (as Clavulanate potassium) USP.............125mg

INDICATION AND USAGE:
To treat the following condition:

Lower respiratory tract infection, acute bacterial otitis media, sinusitis
caused by beta-lactamase- producing isolates of Haemophilus
influenzae and Mozaxela catarhalis, skin-skin structure  infection
caused by beta-lactamase-producing isolates of Staphylococcus
aureus, Escherichia coli and Klebsiella species, Urinary tract infection
caused by beta-lactamase-prodection isolates of Escherichia coli,
Klebsiella and Enterobacter specie.

ADVERSE EFFECTS AND PRECAUTIONS:

See package insert.

STORAGE: Store at temperatures not exceeding 30°C

CAUTION:

Foods, Drug, Devices and Cosmetics Act prohibits
dispensing without prescription.

ADR REPORTING STATEMENT:

For suspected adverse drug reaction, report to the
FDA: www.fda.gov.ph. Seek medical attention immediately at the first sign of any adverse drug reaction.